Bed Bath & Beyond Inc. Reports Results For Fiscal 2018 Second Quarter

Bed Bath & Beyond (BBBY) PT Lowered to $15 at Wedbush

Wedbush analyst Seth Basham lowered the price target on Bed Bath & Beyond (NASDAQ: BBBY) to $15.00 (from $18.00) while maintaining a Neutral rating.

Basham sees little visibility to a turnaround.

Bed Bath & Beyond (BBBY) PT Lowered to $15 at Loop Capital Following 2Q

Loop Capital analyst Anthony Chukumba lowered the price target on Bed Bath & Beyond (NASDAQ: BBBY) to $15.00 (from $18.00) while maintaining a Hold rating following the company's 2Q earnings report. Net sales were roughly flat to F2Q 2017 at $2.9B. Operating margin declined 310 bps YoY to 2.7% and... More

Bed Bath & Beyond (BBBY) PT Lowered to $14 at JPMorgan

JPMorgan analyst Christoper Horvers lowered the price target on Bed Bath & Beyond (NASDAQ: BBBY) to $14.00 (from $16.00) while maintaining an Underweight rating.

The analyst noted gross margin was "much worse than expected, deleveraging ~280 bps to 33.7% (vs. consensus of 35.0%) driven by higher coupons (amount... More

Bed Bath & Beyond (BBBY) PT Lowered to $18 at Credit Suisse

Credit Suisse analyst Seth Sigman lowered the price target on Bed Bath & Beyond (NASDAQ: BBBY) to $18.00 (from $20.00) while maintaining a Neutral rating.

The analyst commented, "BBBY's Q2 was well below expectations and included its weakest GM in years. The -0.6% comps... More

Bed Bath & Beyond (BBBY) Misses Q2 EPS by 14c

Bed Bath & Beyond (NASDAQ: BBBY) reported Q2 EPS of $0.36, $0.14 worse than the analyst estimate of $0.50. Revenue for the quarter came in at $2.94 billion versus the consensus estimate of $2.96 billion.

Comparable Sales Declined Approximately 0.6%

For earnings history and earnings-related data on Bed Bath & Beyond (BBBY) click here.